All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Cell Type | Target | HLA | Epitope | Inquiry & Datasheet |
TCRJ-CQ132 | Anti-IAV M1 (GILGFVFTL) T Cell Receptor (clone CB2A5), Jurkat Cell Line | T lymphocyte | IAV M1 | HLA-A2 | GILGFVFTL | |
TCRJ-CQ229 | Anti-IAV M1 (GILGFVFTL) T Cell Receptor (clone JM22), Jurkat Cell Line | T lymphocyte | IAV M1 | HLA-A2 | GILGFVFTL | |
TCRJ-CQ230 | Anti-IAV M1 (GILGFVFTL) T Cell Receptor (clone PF6), Jurkat Cell Line | T lymphocyte | IAV M1 | HLA-A2 | GILGFVFTL | |
TCRJ-CQ231 | Anti-IAV M1 (GILGFVFTL) T Cell Receptor (clone PF8), Jurkat Cell Line | T lymphocyte | IAV M1 | HLA-A2 | GILGFVFTL | |
TCRJ-CQ232 | Anti-IAV M1 (GILGFVFTL) T Cell Receptor (clone V(beta)17V(alpha)10.2), Jurkat Cell Line | T lymphocyte | IAV M1 | HLA-A2 | GILGFVFTL | |
XS-0623-ZP165 | Anti-IAV M1 TCR-NK Cells | TCR-NK | IAV M1 |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION